Selected research
Industry Growth & Trends
Global Drug and Medical Device Testing Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Drug and Medical Device Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Drug and Medical Device Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Drug and Medical Device Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drug and Medical Device Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Drug and Medical Device Testing Services market include SGS, Intertek, Eurofins, Bureau Veritas, TÜV SÜD, DEKRA, UL, TÜV Rheinland and NAMSA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Drug and Medical Device Testing Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drug and Medical Device Testing Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug and Medical Device Testing Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug and Medical Device Testing Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Drug and Medical Device Testing Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drug and Medical Device Testing Services Market by Company
SGS
Intertek
Eurofins
Bureau Veritas
TÜV SÜD
DEKRA
UL
TÜV Rheinland
NAMSA
BSI Group
Jiangsu Bioperfectus Technologies Co.,Ltd.
SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co.
Henan Zhongmei Technical Inspection Service Co.
Wuxi New Drug Development Co., Ltd. Shanghai
Drug and Medical Device Testing Services Segment by Type
Drug Testing
Medical Device Testing
Drug and Medical Device Testing Services Segment by Application
Pharmaceutical
Medical Instruments
Drug R&D and Clinical Trials
Others
Drug and Medical Device Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug and Medical Device Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug and Medical Device Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug and Medical Device Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drug and Medical Device Testing Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Testing
- Medical Device Testing
Applications
- Pharmaceutical
- Medical Instruments
- Drug R&D and Clinical Trials
- Others
Companies covered
- SGS
- Intertek
- Eurofins
- Bureau Veritas
- TÜV SÜD
- DEKRA
- UL
- TÜV Rheinland
- NAMSA
- BSI Group
- Jiangsu Bioperfectus Technologies Co.,Ltd.
- SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co.
- Henan Zhongmei Technical Inspection Service Co.
- Wuxi New Drug Development Co., Ltd. Shanghai
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Drug and Medical Device Testing Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Drug and Medical Device Testing Services Market Size by Region (2021-2032)
- 1.4.1 Global Drug and Medical Device Testing Services Market Size by Region (2021-2026)
- 1.4.2 Global Drug and Medical Device Testing Services Market Size by Region (2027-2032)
- 1.5 Key Regions Drug and Medical Device Testing Services Market Size (2021-2032)
- 1.5.1 North America Drug and Medical Device Testing Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Drug and Medical Device Testing Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Drug and Medical Device Testing Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Drug and Medical Device Testing Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Drug and Medical Device Testing Services Market Size Growth Rate (2021-2032)
2 Drug and Medical Device Testing Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Drug Testing
- 2.1.2 Medical Device Testing
- 2.2 Global Drug and Medical Device Testing Services Market Size by Type
- 2.2.1 Global Drug and Medical Device Testing Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Drug and Medical Device Testing Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Drug and Medical Device Testing Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Drug and Medical Device Testing Services Market Size by Regions
- 2.3.1 North America Drug and Medical Device Testing Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Drug and Medical Device Testing Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Drug and Medical Device Testing Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Drug and Medical Device Testing Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Drug and Medical Device Testing Services Market Size Breakdown by Type (2021-2026)
3 Drug and Medical Device Testing Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical
- 3.1.2 Medical Instruments
- 3.1.3 Drug R&D and Clinical Trials
- 3.1.4 Others
- 3.2 Global Drug and Medical Device Testing Services Market Size by Application
- 3.2.1 Global Drug and Medical Device Testing Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Drug and Medical Device Testing Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Drug and Medical Device Testing Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Drug and Medical Device Testing Services Market Size by Regions
- 3.3.1 North America Drug and Medical Device Testing Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Drug and Medical Device Testing Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Drug and Medical Device Testing Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Drug and Medical Device Testing Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Drug and Medical Device Testing Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Drug and Medical Device Testing Services Industry Trends
- 4.2 Drug and Medical Device Testing Services Industry Drivers
- 4.3 Drug and Medical Device Testing Services Industry Opportunities and Challenges
- 4.4 Drug and Medical Device Testing Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Drug and Medical Device Testing Services Revenue (2021-2026)
- 5.2 Global Drug and Medical Device Testing Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Drug and Medical Device Testing Services Key Company Headquarters & Area Served
- 5.4 Global Drug and Medical Device Testing Services Company, Product Type & Application
- 5.5 Global Drug and Medical Device Testing Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Drug and Medical Device Testing Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Drug and Medical Device Testing Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Drug and Medical Device Testing Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 SGS
- 6.1.1 SGS Company Information
- 6.1.2 SGS Business Overview
- 6.1.3 SGS Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 SGS Drug and Medical Device Testing Services Product Portfolio
- 6.1.5 SGS Recent Developments
- 6.2 Intertek
- 6.2.1 Intertek Company Information
- 6.2.2 Intertek Business Overview
- 6.2.3 Intertek Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Intertek Drug and Medical Device Testing Services Product Portfolio
- 6.2.5 Intertek Recent Developments
- 6.3 Eurofins
- 6.3.1 Eurofins Company Information
- 6.3.2 Eurofins Business Overview
- 6.3.3 Eurofins Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Eurofins Drug and Medical Device Testing Services Product Portfolio
- 6.3.5 Eurofins Recent Developments
- 6.4 Bureau Veritas
- 6.4.1 Bureau Veritas Company Information
- 6.4.2 Bureau Veritas Business Overview
- 6.4.3 Bureau Veritas Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bureau Veritas Drug and Medical Device Testing Services Product Portfolio
- 6.4.5 Bureau Veritas Recent Developments
- 6.5 TÜV SÜD
- 6.5.1 TÜV SÜD Company Information
- 6.5.2 TÜV SÜD Business Overview
- 6.5.3 TÜV SÜD Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 TÜV SÜD Drug and Medical Device Testing Services Product Portfolio
- 6.5.5 TÜV SÜD Recent Developments
- 6.6 DEKRA
- 6.6.1 DEKRA Company Information
- 6.6.2 DEKRA Business Overview
- 6.6.3 DEKRA Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 DEKRA Drug and Medical Device Testing Services Product Portfolio
- 6.6.5 DEKRA Recent Developments
- 6.7 UL
- 6.7.1 UL Company Information
- 6.7.2 UL Business Overview
- 6.7.3 UL Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 UL Drug and Medical Device Testing Services Product Portfolio
- 6.7.5 UL Recent Developments
- 6.8 TÜV Rheinland
- 6.8.1 TÜV Rheinland Company Information
- 6.8.2 TÜV Rheinland Business Overview
- 6.8.3 TÜV Rheinland Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 TÜV Rheinland Drug and Medical Device Testing Services Product Portfolio
- 6.8.5 TÜV Rheinland Recent Developments
- 6.9 NAMSA
- 6.9.1 NAMSA Company Information
- 6.9.2 NAMSA Business Overview
- 6.9.3 NAMSA Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 NAMSA Drug and Medical Device Testing Services Product Portfolio
- 6.9.5 NAMSA Recent Developments
- 6.10 BSI Group
- 6.10.1 BSI Group Company Information
- 6.10.2 BSI Group Business Overview
- 6.10.3 BSI Group Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 BSI Group Drug and Medical Device Testing Services Product Portfolio
- 6.10.5 BSI Group Recent Developments
- 6.11 Jiangsu Bioperfectus Technologies Co.,Ltd.
- 6.11.1 Jiangsu Bioperfectus Technologies Co.,Ltd. Company Information
- 6.11.2 Jiangsu Bioperfectus Technologies Co.,Ltd. Business Overview
- 6.11.3 Jiangsu Bioperfectus Technologies Co.,Ltd. Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Jiangsu Bioperfectus Technologies Co.,Ltd. Drug and Medical Device Testing Services Product Portfolio
- 6.11.5 Jiangsu Bioperfectus Technologies Co.,Ltd. Recent Developments
- 6.12 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co.
- 6.12.1 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Company Information
- 6.12.2 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Business Overview
- 6.12.3 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Drug and Medical Device Testing Services Product Portfolio
- 6.12.5 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Recent Developments
- 6.13 Henan Zhongmei Technical Inspection Service Co.
- 6.13.1 Henan Zhongmei Technical Inspection Service Co. Company Information
- 6.13.2 Henan Zhongmei Technical Inspection Service Co. Business Overview
- 6.13.3 Henan Zhongmei Technical Inspection Service Co. Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Henan Zhongmei Technical Inspection Service Co. Drug and Medical Device Testing Services Product Portfolio
- 6.13.5 Henan Zhongmei Technical Inspection Service Co. Recent Developments
- 6.14 Wuxi New Drug Development Co., Ltd. Shanghai
- 6.14.1 Wuxi New Drug Development Co., Ltd. Shanghai Company Information
- 6.14.2 Wuxi New Drug Development Co., Ltd. Shanghai Business Overview
- 6.14.3 Wuxi New Drug Development Co., Ltd. Shanghai Drug and Medical Device Testing Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Wuxi New Drug Development Co., Ltd. Shanghai Drug and Medical Device Testing Services Product Portfolio
- 6.14.5 Wuxi New Drug Development Co., Ltd. Shanghai Recent Developments
7 North America
- 7.1 North America Drug and Medical Device Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 7.3 North America Drug and Medical Device Testing Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Drug and Medical Device Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 8.3 Europe Drug and Medical Device Testing Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drug and Medical Device Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Drug and Medical Device Testing Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Drug and Medical Device Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 10.3 South America Drug and Medical Device Testing Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drug and Medical Device Testing Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Drug and Medical Device Testing Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Drug and Medical Device Testing Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst